NCT07072702 Feasibility and Acceptability of an Evidence-Informed Virtual Intervention to Reduce Perceptions of Injustice Following Work Injury
| NCT ID | NCT07072702 |
| Status | Recruiting |
| Phase | — |
| Sponsor | McGill University |
| Condition | MSK Conditions |
| Study Type | INTERVENTIONAL |
| Enrollment | 75 participants |
| Start Date | 2024-09-30 |
| Primary Completion | 2026-03-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 75 participants in total. It began in 2024-09-30 with a primary completion date of 2026-03-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Many individuals who have sustained disabling injuries in the workplace react to their situation with a sense of 'injustice'. Research over the past 20 years has revealed that, interpreting one's post-injury life situation as 'unjust', actually interferes with recovery from the disabling injury. Post-injury perceptions of injustice contribute to more severe pain, more severe symptoms of depression and PTSD, and more prolonged absence from work. Several clinical researchers have highlighted the need to develop approaches to treatment that can reduce post-injury perceptions of injustice. A brief intervention was developed to reduce post-injury perceptions of injustice. The intervention consists of 4 30-minute sessions with a psychologist. The intervention is called 'Managing Post-Injury Challenges' (MPIC). The MPIC sessions are delivered virtually (online). As a first step toward determining whether MPIC has added value for promoting more successful recovery following work injury, the proposed research will assess the feasibility of MPIC. Some of the feasibility questions that will be addressed include: Are injured workers interested in participating in MPIC? Do injured individuals remain sufficiently engaged to complete all 4 sessions of MPIC? Does participation in MPIC contribute to meaningful reductions in perceived injustice? And are injured individuals satisfied with the benefits of MPIC? MPIC differs from many other rehabilitation interventions in that it focuses on a 'risk-factor' for problematic recovery as opposed to treating a specific health or mental health problem. At this time, there is little information about whether injured workers are interested in interventions focusing on 'risk factors' for problematic recovery. As a first step in evaluating the effectiveness of MPIC, it is necessary to demonstrate that MPIC is acceptable to injured workers. We would consider the study to be successful if 1) at least 75% of eligible injured workers agree to enrol in MPIC, 2) if at least 75% of participants attend all 4 sessions of MPIC, and if at least 75% of participants are satisfied with the benefits they derived from their involvement in MPIC. If MPIC is ultimately shown to be effective in reducing post-injury perceptions of injustice, offering MPIC to injured workers with elevated scores on a measure of perceived injustice could contribute to more successful recovery.
Eligibility Criteria
Inclusion Criteria: 1. working knowledge of English, 2. work absence of less than 8 weeks duration following a musculoskeletal injury to the back or neck, 3. a score above clinical threshold on a self-report measure of perceived injustice, 4. between 25 and 65 years of age, 5. referred for primary care physiotherapy, and 6. currently receiving wage indemnity benefits from the WSIB. Exclusion Criteria: 1. currently receiving psychological services for a mental health problem, 2. clinical evidence of vertebral fracture, disk herniation, infectious disease, or rheumatoid arthritis (determined from referral information), 3. illiteracy or severe cognitive impairment (determined informally through the intake interview).
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07072702 clinical trial?
This trial is open to participants of all sexes, aged 25 Years or older, up to 65 Years, studying MSK Conditions. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07072702 currently recruiting?
Yes, NCT07072702 is actively recruiting participants. Contact the research team at michael.sullivan@mcgill.ca for enrollment information.
Where is the NCT07072702 trial being conducted?
This trial is being conducted at Montreal, Canada.
Who is sponsoring the NCT07072702 clinical trial?
NCT07072702 is sponsored by McGill University. The trial plans to enroll 75 participants.